Literature DB >> 26632192

DOWN'S SYNDROME WITH NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO HLA-A2 ANTIBODY.

Toshihiko Nakamura1, Tomoaki Nomura, Takashi Kamohara, Hidehiro Takahashi, Daisuke Hatanaka, Michiko Kusakari, Mari Nakamura, Kinuyo Kawabata, Hitoshi Ohto.   

Abstract

Anti-HLA antibodies reportedly exist in the one third of pregnant women. But few occurrences of neonatal alloimmune thrombocytopenia (NAIT) caused by anti-HLA antibodies have been reported. Here a male baby, who was admitted for low birth weight with Down syndrome (DS), was suffered from thrombocytopenia without transient myeloproliferative disorder (TMD). Positive reactions of HLA-specific antibodies were detected in maternal serum. Cross-matching tests between maternal serum and paternal platelets and lymphocytes were strongly positive. It is most conceivable that the previous pregnancy of the mother induced the production of anti-HLA-A2 antibody, which crossed the placenta and subsequently caused an NAIT in the case presented. This is the first case of DS with NAIT due to anti-HLA antibodies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26632192      PMCID: PMC5131590          DOI: 10.5387/fms.2015-19

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  20 in total

Review 1.  The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.

Authors:  B Lange
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

Review 2.  Antenatal screening for fetomaternal alloimmune thrombocytopenia: should we be doing it?

Authors:  M F Murphy; L M Williamson; S J Urbaniak
Journal:  Vox Sang       Date:  2002-08       Impact factor: 2.144

3.  The placental pathology of small-for-gestational age infants.

Authors:  G Altshuler; P Russell; R Ermocilla
Journal:  Am J Obstet Gynecol       Date:  1975-02-01       Impact factor: 8.661

4.  Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study.

Authors:  Fawaz Al-Kasim; John J Doyle; Gita V Massey; Howard J Weinstein; Alvin Zipursky
Journal:  J Pediatr Hematol Oncol       Date:  2002-01       Impact factor: 1.289

5.  Thrombocytopenia in neonates with trisomy 21.

Authors:  J D Hord; J C Gay; J A Whitlock
Journal:  Arch Pediatr Adolesc Med       Date:  1995-07

Review 6.  Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review.

Authors:  M M Kamphuis; N Paridaans; L Porcelijn; M De Haas; C E Van Der Schoot; A Brand; G J Bonsel; D Oepkes
Journal:  BJOG       Date:  2010-10       Impact factor: 6.531

Review 7.  International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001.

Authors:  Peter A Lee; Steven D Chernausek; Anita C S Hokken-Koelega; Paul Czernichow
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

Review 8.  A systematic review and survey of the management of unexpected neonatal alloimmune thrombocytopenia.

Authors:  Dirk Bassler; Andreas Greinacher; Chusak Okascharoen; Anne Klenner; Juliana Ditomasso; Volker Kiefel; Anthony Chan; Bosco Paes
Journal:  Transfusion       Date:  2007-09-24       Impact factor: 3.157

9.  Association of neonatal thrombocytopenia and maternal anti-HLA antibodies.

Authors:  N Koyama; Y Ohama; K Kaneko; Y Itakura; T Nakamura; J Takasaki; T Tanaka; H Eguchi; A Kawase; K Kamiya
Journal:  Acta Paediatr Jpn       Date:  1991-02

10.  Hematological abnormalities in newborn infants with Down syndrome.

Authors:  M Miller; J M Cosgriff
Journal:  Am J Med Genet       Date:  1983-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.